Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Bitcoin Trust
IBIT
|
+$651M |
| 2 |
Fidelity Wise Origin Bitcoin Fund
FBTC
|
+$622M |
| 3 |
Merck
MRK
|
+$496M |
| 4 |
Adobe
ADBE
|
+$446M |
| 5 |
CRH
CRH
|
+$410M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$4.33B |
| 2 |
Microsoft
MSFT
|
+$965M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$542M |
| 4 |
NVIDIA
NVDA
|
+$522M |
| 5 |
Linde
LIN
|
+$377M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.55% |
| 2 | Healthcare | 6.96% |
| 3 | Financials | 6.02% |
| 4 | Industrials | 5.05% |
| 5 | Consumer Discretionary | 4.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5376
PUT
Pyxis Oncology
PYXS
$255M
| $136K | ﹤0.01% |
+32,000
| New | +$135K |
|
5377
American Battery Technology Co
ABAT
$353M
| $136K | ﹤0.01% |
77,794
+45,924
| +144% | +$117K |
|
5378
Hydrofarm Holdings
HYFM
$4.53M
| $135K | ﹤0.01% |
12,534
-6,337
| -34% | -$57.8K |
|
5379
Security National Financial
SNFCA
$227M
| $133K | ﹤0.01% |
19,508
-13,046
| -40% | -$92K |
|
5380
Stem
STEM
$54M
| $133K | ﹤0.01% |
3,040
-4,224
| -58% | -$235K |
|
5381
First Guaranty Bancshares
FGBI
$145M
| $133K | ﹤0.01% |
13,112
-3,396
| -21% | -$38.8K |
|
5382
CEL-SCI Corp
CVM
$26M
| $133K | ﹤0.01% |
+2,323
| New | +$164K |
|
5383
Journey Medical
DERM
$213M
| $133K | ﹤0.01% |
36,117
-38,914
| -52% | -$169K |
|
5384
TMC The Metals Company
TMC
$2.19B
| $132K | ﹤0.01% |
+92,653
| New | +$129K |
|
5385
BGSF Inc
BGSF
$57.7M
| $132K | ﹤0.01% |
12,693
-7,141
| -36% | -$71.1K |
|
|
HYZN
5386
DELISTED
Hyzon Motors Inc. Class A Common Stock
HYZN
| $131K | ﹤0.01% |
3,566
-777
| -18% | -$26.7K |
|
|
VINC
5387
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
| $131K | ﹤0.01% |
1,297
-426
| -25% | -$26.9K |
|
5388
Monopar Therapeutics
MNPR
$744M
| $131K | ﹤0.01% |
38,476
+32,608
| +556% | +$97.2K |
|
5389
DHT Holdings
DHT
$3.09B
| $131K | ﹤0.01% |
11,372
-392
| -3% | -$4.3K |
|
5390
CALL
Melco Resorts & Entertainment
MLCO
$2.08B
| $131K | ﹤0.01% |
18,100
-441,900
| -96% | -$3.55M |
|
|
CKPT
5391
DELISTED
Checkpoint Therapeutics
CKPT
| $130K | ﹤0.01% |
63,433
+51,512
| +432% | +$103K |
|
|
EEX
5392
DELISTED
Emerald Holding
EEX
| $129K | ﹤0.01% |
19,005
+5,283
| +39% | +$32.6K |
|
|
VFSWW
5393
CALL
VinFast Auto Ltd Warrant
VFSWW
| $129K | ﹤0.01% |
183,850
| – | – |
|
|
LFT
5394
Lument Finance Trust
LFT
$36.5M
| $129K | ﹤0.01% |
51,651
+23,830
| +86% | +$56.1K |
|
5395
InfuSystem Holdings
INFU
$239M
| $128K | ﹤0.01% |
+14,885
| New | +$140K |
|
5396
BioXcel Therapeutics
BTAI
$23.2M
| $127K | ﹤0.01% |
2,820
-2,677
| -49% | -$128K |
|
5397
China Yuchai International
CYD
$1.48B
| $126K | ﹤0.01% |
14,825
-13,059
| -47% | -$113K |
|
|
NMG
5398
Nouveau Monde Graphite
NMG
$487M
| $126K | ﹤0.01% |
55,190
+41,703
| +309% | +$97.3K |
|
5399
CALL
Enovix
ENVX
$742M
| $126K | ﹤0.01% |
+17,943
| New | +$156K |
|
5400
Novavax
NVAX
$1.56B
| $125K | ﹤0.01% |
26,228
-394,198
| -94% | -$1.83M |
|
Similar funds
Israel Englander's Q1 2024 Portfolio in Review
As of Q1 2024, Israel Englander held 6,887 positions worth $234B, up 1.3% from $231B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Israel Englander withdrew a net $25.1B in Q1 2024, closing 745 positions and reducing 2,484 holdings. Its most notable exit was Splunk Inc, an estimated $319M position sold in full.
By sector, the portfolio is most concentrated in Technology at 8.5% of assets, up from 8.3% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Israel Englander opened a new position in iShares Bitcoin Trust worth $844M.
- Israel Englander's largest Q1 2024 buy was iShares Bitcoin Trust: 20,859,447 shares worth $844M.
- Israel Englander added most to Merck in Q1 2024, an estimated $496M increase.
- Israel Englander's biggest Q1 2024 reduction was iShares Core S&P 500 ETF, cutting an estimated $4.33B.
- Israel Englander fully exited Splunk Inc in Q1 2024, selling an estimated $319M.
- Israel Englander's ten largest holdings make up 17% of its $234B portfolio in Q1 2024.
- Israel Englander opened 858 new positions and closed 745 in Q1 2024.
- Israel Englander's portfolio value rose 1.3% quarter-over-quarter to $234B.
Based on Millennium Management's 13F filing for Q1 2024, filed 15 May 2024.